Podcasts about daver

Dive into the fascinating intersection of consciousness and creativity where the dreamworld becomes a personal “Choose Your Own Adventure” playground. For this dream, I'm joined by Dave Green to discuss Doodles in the Dark, An Artist's Guide to Lucid Dreaming. We'll investigate unique methods, focusing on the thrill of creating art directly within a lucid state rather than simply drawing after the fact. We discuss practical nightly routines such as using “interdimensional dream stationery” to maintain a sense of continuity between physical and dream realities. And we'll navigate everything from interactions with unpredictable dream characters to the profound meditative stillness of the “lucid void”. Get the book: https://amzn.to/4vwiD1l More on Dave: https://dave-green.co.uk/ Get The Occult Elvis: https://amzn.to/4jnTjE4 Virtual Alexandria Academy: https://thegodabovegod.com/virtual-alexandria-academy/ Gnostic Tarot Readings: https://thegodabovegod.com/gnostic-tarot-reading/ The Gnostic Tarot: https://www.makeplayingcards.com/sell/synkrasis Homepage: https://thegodabovegod.com/ Patreon: https://www.patreon.com/aeonbyte AB Prime: https://thegodabovegod.com/members/subscription-levels/ Voice Over services: https://thegodabovegod.com/voice-talent/ Support with donation: https://buy.stripe.com/00g16Q8RK8D93mw288 Merch store: https://aeonbyte.creator-spring.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode #256 features Shernaz Daver, one of Silicon Valley's most respected executive advisors and communications strategists, who has worked alongside leaders including Steve Jobs, Netflix co-founder Reed Hastings, Khosla Ventures founder Vinod Khosla and Waymo/Udacity founder Sebastian Thrun. In conversation with Vidit Agarwal, Shernaz reflects on a remarkable journey shaped across India, Japan and the United States — from growing up between cultures as part of the small Zoroastrian community to navigating the inner circles of Silicon Valley's most influential founders and companies. She shares stories from Motorola, Electronic Arts and Sun Microsystems, the rejection that changed her trajectory, the unforgettable moment Steve Jobs told her she had done a “terrible job” marketing a product, and the lessons she learned working alongside elite founders and operators. The conversation also explores insecurity, ambition, storytelling, AI, burnout, hype versus reality in Silicon Valley, and what separates visionary leaders from merely successful ones. Please enjoy exploring your curiosity. ________ Get in touch with us via email at contact@curiositycentre.com Join our stable of commercial partners including the Australian Government, Google, KPMG, Vanta, Allens, Macquarie Capital, City of Sydney and more.  Show notes and more episodes here Follow us on LinkedIn, Twitter, Instagram, or YouTube Get in touch with our Founder and Host, Vidit Agarwal directly here Contact us via our website ________ The High Flyers Podcast features in-depth interviews with the world's most influential figures in business, tech, finance, government and sport. Launched in 2020, it has ranked in the global top ten for past three years, with listeners in 27 countries and over 200+ episodes released, and featured in Forbes, Daily Telegraph, and at SXSW. Our guests include -- Malcolm Turnbull (Prime Minister of Australia), Anil Sabharwal (Global VP, Product at Google), Jason Collins (Head of BlackRock, Asia Pacific), Jodie Auster (Uber's Global Head of Travel), Stevie Case (Chief Revenue Officer, Vanta), Brad Banducci (CEO, Woolworths),  David Haber (GP, a16z), Rob Giglio (CCO, Canva), Jean-Michel Lemieux (CTO, Shopify + Atlassian), Sweta Mehra (EGM, NAB; ex CMO, ANZ), Bowen Pan (Creator, Facebook Marketplace), Sam Sicilia (Chief Investment Officer, Hostplus), Craig Tiley (CEO, US Tennis), John Haddock (CBO, Harvey), Niki Scevak (Co-Founder, Blackbird Ventures), Mike Schneider (CEO, Bunnings), Trent Cotchin (3x Premiership Winning Captain, Richmond FC), Peter Varghese (Secretary of Foreign Affairs, Australian Government), Jack Zhang (CEO, Airwallex), Matteo Franceschetti (CEO, Eight Sleep), Vivek Bhatia (CEO, MUFG), Sanjeev Gandhi (CEO, Orica) and more. 

In this podcast, experts Naval G. Daver, MD; Amir Fathi, MD; Guillermo Garcia-Manero, MD; and Aditi Shastri, MD, discuss current applications for menin inhibitors in patients with acute leukemia, combination approaches under investigation, and managing treatment-related adverse events with menin inhibitors.

Visuals: https://getbehindthebillboard.com/episode-105-yohan-daver This Friday sees the last in our New York specials and we're finishing with a cracker, Yohan Daver, ECD at at BBH, USA Yohan started his career in India, at BBDO and then BBH, before continuing his journey with the black sheep to LA and now BBH New York. Yohan's work has been recognised at every major awards show, winning big at Cannes, D&AD, The One Show, and the Clios. We discussed some of his very best campaigns, starting with Netflix's Squid Game: The Challenge, a genuinely intriguing, funny and superbly on-brand campaign that questioned the morals of New Yorkers and what they would do for money. Next we covered the ‘Black-owned Friday Every Day' initiative for Google in partnership with the U.S. Black Chambers, Inc. to reframe the busiest shopping day of the year as a celebration of Black-owned businesses. We did a quick bit of Heineken, before finishing on Dunkin' at Home which we've loved ever since we saw it last year. It is the epitome of great OOH, fantastic idea, brilliantly executed. Yohan gave us the story behind the idea which is not to be missed. Then we chatted about the beautifully crafted execution. It deservedly won our International Poster of the year and we imagine it will clean up in the awards shows later this year. Thanks again Yohan for coming on. A great end to a fun week. Huge thanks once again to Joe at Rockefeller Center's Newsstand Studios for making us sound (semi)professional. Thanks also to our all our guests both in the studio and at AdFest, you were all amazing. Kudos as ever to Jon for the edits. Gas for the music. And the good people of New York who made us feel so welcome. V much hoping to return. BTB ❤️ NYC And as ever, huge thanks to all our sponsors, who make the show possible: Bauer Media Outdoor View2Fill Super Optimal GAS Music

In this episode of the Oncology Brothers podcast, we discussed two challenging cases focused on Acute Myeloid Leukemia (AML). We welcomed Dr. Naval Daver, a leading expert from MD Anderson Cancer Center, to discuss: therapy-related AML and de novo AML where induction chemotherapy is not an option. Episode Highlights: • Overview of therapy-related AML and its increasing prevalence due to advancements in solid tumor treatments. • In-depth discussion on the prognosis and treatment options for patients with complex cytogenetics. • Comparison of induction treatments: CPX-351 vs. the traditional 7 + 3 regimen, including survival rates and side effects. • Insights into the use of hypomethylating agents combined with venetoclax for older patients with AML, particularly those with NPM1 mutations. • Practical considerations for administering these treatments in both inpatient and outpatient settings. Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode provides valuable insights into the complexities of AML management. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more discussions on treatment algorithms, conference highlights, and the latest FDA approvals! #AcuteMyeloidLeukemia, #TherapyRelatedAML, #DeNovoAML, #TransplantIneligible, #OncologyBrothers

Thanks Bill!

The artificial sweetener sucralose may impair the efficacy of cancer immunotherapy, according to a recent study published in Science. Although further research is needed before these findings can be translated into actionable information for patients, the investigation highlights that “the science of nutrition in cancer is actually quite poor,” says senior author Diwakar Davar, MD, associate professor and clinical director of the melanoma and skin cancer program at the University of Pittsburgh School of Medicine Hillman Cancer Center in Pennsylvania. Dr. Daver shared why he and his colleagues chose to explore the potential effects of sucralose on cancer treatment, and what research is next, with Robert A. Figlin, MD, the interim director of Cedars-Sinai Cancer in Los Angeles and Steven Spielberg Family Chair. “What I think we are hoping to try to do is actually just kickstart a movement to get people to focus on nutrition,” Dr. Daver explained. “We spend $1 billion to try to get a hazard ratio of 0.8, and here it appears that if you eat just a little less of this, you can maybe double your likelihoods of success.” Dr. Davar reported various financial relationships. Dr. Figlin reported various financial relationships.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WFS865. CME credit will be available until August 21, 2026.All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Johnson & Johnson, Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KEE865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2026.Winning GAMBITS Against AML: Guidance on Advances & Medical Breakthroughs with Innovative Targeted Strategies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Astellas, Daiichi Sankyo, Inc., Johnson & Johnson, Kura Oncology, Inc., Rigel Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and Syndax.Disclosure information is available at the beginning of the video presentation.

In today's episode, we spoke with Naval Daver, MD, about the evolving role of menin inhibition in acute myeloid leukemia (AML) and emerging data with revumenib (Revuforj) presented across ongoing clinical trials. Dr Daver is a professor in the Department of Leukemia and director of the Leukemia Research Alliance Program at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Host: Jennifer Caudle, DO Guest: Naval Daver, MD Not only is CD123 one of the most common antigens expressed on the surface of acute myeloid leukemia (AML) tumors, but it's also associated with more proliferative disease that's resistant to standard therapies. Given its prevalence and potential implications, a number of different CD123-targeting approaches are under investigation, including antibody-drug conjugates, bi-specific antibodies, fusion protein, and CAR T-cell therapy. In light of these new approaches, Dr. Jennifer Caudle and Dr. Naval Daver discuss the importance of targeting CD123 in AML. Dr. Daver is a Professor and Director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center in Houston.

Host: Jennifer Caudle, DO Guest: Naval Daver, MD Not only is CD123 one of the most common antigens expressed on the surface of acute myeloid leukemia (AML) tumors, but it's also associated with more proliferative disease that's resistant to standard therapies. Given its prevalence and potential implications, a number of different CD123-targeting approaches are under investigation, including antibody-drug conjugates, bi-specific antibodies, fusion protein, and CAR T-cell therapy. In light of these new approaches, Dr. Jennifer Caudle and Dr. Naval Daver discuss the importance of targeting CD123 in AML. Dr. Daver is a Professor and Director of the Leukemia Research Alliance Program in the Department of Leukemia at MD Anderson Cancer Center in Houston.

On this episode of "The HemOnc Pulse," Naval Daver, MD, of the MD Anderson Cancer Center, joins Chadi Nabhan, MD, MBA, FACP, to discuss news on acute myeloid leukemia coming out of the Twelfth Annual Meeting of the Society of Hematologic Oncology in Houston, Texas.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by independent educational grants from AbbVie, Actinium Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by independent educational grants from AbbVie, Actinium Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by independent educational grants from AbbVie, Actinium Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by independent educational grants from AbbVie, Actinium Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/HGC865. CME/MOC/NCPD/CPE credit will be available until October 5, 2025.Opportunity Knocks in AML: Guidance on Achieving Truly Personalized Care in Challenging Populations with Modern Therapeutics In support of improving patient care, Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by independent educational grants from AbbVie, Actinium Pharmaceuticals, Astellas, Daiichi Sankyo, Inc., Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies), Kura Oncology, Inc., and Syndax.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative Therapeutics In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Astellas, Bristol Myers Squibb, Daiichi Sankyo, Inc., Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative Therapeutics In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Astellas, Bristol Myers Squibb, Daiichi Sankyo, Inc., Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative Therapeutics In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Astellas, Bristol Myers Squibb, Daiichi Sankyo, Inc., Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative Therapeutics In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Astellas, Bristol Myers Squibb, Daiichi Sankyo, Inc., Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/YGR865. CME/MOC/NCPD/AAPA/IPCE credit will be available until July 1, 2025.Unleashing the Innovation Era in AML: Practice Principles and Precision Medicine With Innovative Therapeutics In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and HealthTree Foundation for Acute Myeloid Leukemia. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from AbbVie, Astellas, Bristol Myers Squibb, Daiichi Sankyo, Inc., Kura Oncology, Inc., and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Shiur given by Rabbi Bezalel Rudinsky on Dvar Halacha Yom Tov. Shiur recorded in Yeshivas Ohr Reuven, Monsey, NY.

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia | Faculty Presentation 2: Available and Emerging Nontargeted Therapies for AML — Naval Daver, MD CME information and select publications

Gus and Pat Ford are in studio as Kirk complains about a garbage truck he was stuck behind. (1:15) Kirk comments on how strange Gus looks today. (3:35) Harry Minihane celebrates his 12th birthday. (06:00) Gus has plans for a new Puff Puff Piece podcast. (07:35) Kirk is down on a lot of fast casual restaurants. (10:15) Gus is heading to a wedding in Minnesota, and Coleman looks back on his hatred for the state. (19:00) Pat Ford explains peanut oil. (24:00) Gus gets a Target gift card as a wedding gift. (25:00) Coleman and Mut have a budding rivalry. (28:15) Mut calls in. (53:35) Kirk previews tonight's Dozen match. (58:35) Gus and Pat discuss the beef between Mick and Al. (59:35) Commissioner Jeff D. Lowe calls in. (01:12:00) Kirk listens to the latest KMScenes with Steve from Glosta's friends. (01:13:55) Cinema Lords takes his jabs at Steve from Glosta. (01:14:15) Alec Baldwin was harassed at a coffee shop. (01:21:35) Kirk is no longer mad at Kayce, but she blocked Pat Ford. (01:25:00) Daver is slowly crawling back into the world. (01:25:35) Mick went on the Socially Awkward podcast to discuss his breakup with Jess. (01:28:00) Pat Ford was scammed by Montante. (01:44:35) People's Republic of Coleman knows a gay porn star. (01:46:45) Klemmer continues to impersonate Kirk. (01:59:00) Looking back on Steve Robinson and the Covid episodes. (02:01:00) Gus announces an upcoming Patreon.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Danny in Billerica joins Kirk in studio as Robbie V. makes his debut. (3:10) Robbie explains the Wonk of the Week. (9:15) The Robbie V. Experience. (18:00) Ohio's Tate calls in to discuss Kirk calling him his least favorite person at the company. (21:37) Tate claims he was trying to help Kirk out. (28:30) Francis revealed on Son of a Boy Dad that Chris Castellani had included a false story of him harassing a coworker in the first draft of his response blog. (30:35) Chris Castellani calls in. (36:35) Robbie V. asks about the future of The Robbie V. Show. (38:05) Alice Shattuck seemed a tad drunk on the debut of The Leeches Podcast. (38:05) Talking babies. (48:45) Graham B. calls in from a Greyhound bus. (50:45) Danny gives a Daver update. (01:08:00) Kirk's Lock of the Week is that the Shattuck's will have an incestuous child. (01:14:05) Robbie V. exposes Coleman as a fake BC fan. (01:26:45) Robbie V. used to have a flip phone. (01:31:40) Kirk thinks there may be mutual feelings between Steve from Glosta and Kayce Smith. (01:39:10) Justin accepts that Star Wars is ruined. (01:46:10) Kirk wants to babysit. (01:57:15) Talking diapers. (02:03:50) Robbie V. is a man of loyalty.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Kirk is in Chicago with Mark Titus and Jeff D. Lowe producing, immediately following the all-night Draft Kings Free Throw Challenge. (1:00) Kirk and Titus recap the stream. (6:00) Kirk's Winners and Losers List of the stream. (10:05) Recapping the additional shooters who joined the stream. (14:35) Titus breaks down his beef with Marty and mends fences with Kirk. (19:00) Jeff recaps his dreadful Yak challenge attempt. (24:00) Coleman may be in for a rough day Thursday due to resurfaced tweets to Bailey Carlin. (32:25) Red and Blind Owl were going at it on X over the weekend. (33:54) Big Cat joins. (44:50) Big Cat reveals who slept through the celebration. (46:35) Big Cat apologized to Klemmer for being cold to him when he first joined Barstool. (49:25) Kirk is sick of Brandon repeating the same joke. (53:05) Big Cat lists his Winners and Losers of the stream. (55:25) Big Cat thinks if another team breaks their record, they should do the free throw challenge again. (01:00:35) Kirk and Big Cat tease an announcement around The Masters. (01:02:05) Big Cat recaps Rico's Super Bowl. (01:07:55) Gerry's reaction to Usher's halftime show. (01:09:55) Kirk has a hot take about Taylor Swift and Donna Kelce. (01:11:55) Coleman thinks RFK Jr. lost the election with his Super Bowl ad. (01:15:25) Kirk reveals his golf gambling podcast with Riggs is making a return. (01:17:00) Kirk asks Jeff for his take on the Daver gambling scandal. (01:23:39) Star Wars chat.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Andy Mayo and Jon in Warren are in studio as Kirk discusses last night's Barstool Live in Vegas. (9:40) Kirk has no desire to go to space. (18:30) Danny in Billerica went on The Beyond Average Podcast to discuss his co-host Daver. (27:50) The Dozen Live show revealed their celebrity guests. (30:00) Kirk revealed he had a phone call with Erika. (33:00) Data Guy Grier went on TMZ to discuss Shane Gillis. (36:14) Kirk and Justin have a literal dick measuring contest. (43:25) Bobby Costa made a song. (46:50) Looking back at all the past lawsuits against the show. (49:45) Mayo reveals Menners is producing Better Workdays. (58:00) A discussion on therapy. (01:13:10) Mayo and Jon have dreadful questions for Portnoy and Whit. (01:19:00) Disney+ is increasing their annual subscription fee. (01:20:45) There seemed to be pre-show tension between Mayo and Jon. (01:30:15) Kirk listens back to an old Enough About Me. (01:37:40) Ryan Minihane calls in. (01:39:45) Jeff D. Lowe calls in. (01:54:30) Kirk answers why there hasn't been calls recently.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Kirk is joined in studio by Mut and Mike from Shopper's Cafe. (6:00) Coleman had more disturbing tweets surface. (15:00) Justin dug up audio from Coleman's fave podcast. (18:10) Greg Poehler made his network debut on Mt. Kirkmore. (22:30) Kirk reminisces on how he used to go on retreat to talk to girls. (24:30) Justin reads the official statement on Black Lives Matter from Big Picture Sports Group. (35:00) Justin may have been withholding information that he was being fed from Daver. (39:55) Dave Portnoy discussed how Justin and Coleman will be producing The Unnamed Show on The Yak yesterday. (44:30) Hank did a standup set for over an hour last night. (48:00) Mut gives a life update. (56:20) Boomer & Gio booked the wrong Randy Moss. (59:10) Mike gives a breakdown of the pizza business. (01:13:45) Harry has been making small bets with Kirk. (01:19:40) Mut draws the line at betting on dog races. (01:31:10) Mt. Kirkmore's most shocking show moments. (01:45:10) Mut's kids have gotten into prank phone calls. (01:49:40) Carano has another dreadful song. (01:54:30) Kirk ranks his top 10 centers of all time. (01:57:40) Kirk reflects on basketball camp. (02:13:20) Kirk explains why he hasn't been doing marathons anymore.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Kirk is joined in studio by Blind Mike and Joe The Dying Guy. (09:00) Coleman's response to Keegs bashing him on Twitter was incredibly lame. (14:30) Joe discusses his medical history. (26:30) It seems like Daver no longer wants to be a part of the show world. (29:30) BA is potentially compromised after DMing the show account about Daver not placing the parlay. (35:00) Graham Bennett calls back in. (45:30) The M&M Boys are seemingly done with each other. (50:00) Coleman is exposed as double agent, leading to old tweets being dug up. (01:15:40) Jeff D. Lowe calls in. (01:21:20) Mike's old interview with Shane Gillis is brought up on The Rundown. (01:28:25) King Charles III is dying. (01:32:30) Justin saw Argylle last night. (01:35:30) John Cena is a strange guy. (01:40:00) Hank is doing a standup show tonight. (01:49:20) PFT signed a new contract for three more years with Barstool. (01:53:40) Joe takes questions and talks about his podcast. (02:03:35) The kids love Biden, Trump, and Obama AI.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Blind Mike and Beyond Average Mick join Kirk in studio as he remembers the late Carl Weathers. (11:50) Justin recaps his weekend selling snow cones. (13:20) Mick gives a health update. (16:30) Lisa Ann was arrested at a Matt Rife show last night. (17:30) Controversy has struck the Minifan gambling world after VD called out Daver on the latest Rundown. (31:00) Commissioner Jeff D. Lowe calls in to give his take on the Daver news. (35:30) Kirk wonders why Dan Aykroyd was in We Are The World. (37:00) Mick thought Kirk could have done more for him in the latest KMScenes. (45:00) The New York office had a content draft. (51:55) Mick gives an update on his relationship. (57:30) Menners may be trying to stir up fake drama for Network views. (59:00) Adam Riley had a wild stance on the Kevin Cullen story. (01:07:23) Julie appeared on a different podcast. (01:10:50) Biden is calling for airlines to allow families to sit together for free. (01:17:38) Shane Gillis is hosting SNL. (01:20:25) Joe Rogan has a new Spotify deal. (01:29:30) Coleman thinks another former NFL coach is on his way to The Heights. (01:37:30) Daver calls in. (01:45:20) Shark Tank hit a new low. (01:49:00) Justin does another Montante impression. (01:50:20) Mick had a downstairs debate. (01:55:40) VD calls in to dispute Daver's claims. (02:10:40) Daver calls back in, even though he hasn't been listening to the show. (02:37:00) A new season of Curb Your Enthusiasm premiered last night. (02:38:00) Andy Rooney on Kurt Cobain. (02:42:10) Kirk's apple juice story. (02:44:00) Debating if Dave Portnoy could host SNL.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Blind Mike joins Kirk in studio as Justin produces. (1:30) Daver calls in to break down his investigative report. (11:30) Mike gives his theory on Mick's explosive day yesterday. (16:30) Everyone weighs in on the Boner Salad Report. (24:30) Mike discusses how Coleman and Gus messed up. (28:30) Gus is sending around his pitch. (40:00) Justin reveals he ran a skincare company. (42:00) Justin gives a Mountain Dew update. (47:00) Snell is back in the world. (01:02:00) Jeff calls in to discuss Mick's whereabouts. (01:05:00) Mick calls in to give an update. (01:19:00) #DonutGate (01:25:00) "Intern" Nicholas calls in. (01:30:00) MutStack drops. (01:37:00) Castellani is asked about Kirk on a livestream. (01:40:00) Justin gives his thoughts on the newest Star Wars movie announcement. (01:46:00) Calls. (02:09:00) A caller asks Mike for an update on Lauren Compton. (02:20:00) Predictions for next week's show.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Daver joins Kirk in studio with Beyond Average Mick producing as Coleman and Gus serve their suspension. Justin calls in to break down Gus' charger purchase. Gus gains another week of a suspension after tweeting last night. This may be the end of Gus, now that he has broken Kirk's trust. Mick gets caught in a Gus moment by lying about having the audio ready. Kirk thinks Stevey Bits is a phony. Kirk hints at who sent him the Barstool NY email from KFC and gives an update on his friendship with Rico. Kirk calls Jersey Jerry during his seemingly endless hole-in-one stream. Aaron Rodgers called out Jimmy Kimmel for potentially being on the Epstein list. Claudine Gay resigned. Kirk gives his take on Turtleboy and Cullinane. Mick attempts to take calls. Intern Josh calls in to give his side of the Best Of and reveals a secret intern. Kirk offers Gus an opportunity to make a final pitch for his job. Mick gives an update on his relationship with Al.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Daver and Danny review this classic episode from the summer of discontent: Blind Mike interviewed a social media guy at Barstool who has been critical of Dave Portnoy, Kirk Minihane, and Barstool Sports -- and Kirk is infuriated with the results. The guys break down Portnoy's segment on Barstool Radio with the Chicago crew. The AP story about racism and sexual abuse in the Red Sox clubhouse got about as much publicity as you would expect. Alleged sex criminal and Jeff Epstein pal Ghislaine Maxwell is in federal custody and on every suicide watch list imaginable, but will she make it to trial?

“Daver and Danny are joined by McFussdaddy to revisit everyone's favorite morning show: The Hammer on WCXX! Kirk Minihane, Mikey B, & Simply Steve take you through the morning with the billboard's hottest hits. Joseph and Elizabeth sort things out on an all new Time's Up, Mikey B. gets your gears turned with a hot chocolate controversy and a brand new Bro Brain Buster. And of course, it's Thursday, so the boys do a little Shammer or Hammer before things get really lit with the Pizza Topping Draft.”

Julie makes her KMN debut with DaveR and Danny! They discuss Kirk welcoming in his friend Dave Portnoy. Portnoy defends why he allowed a friend to dictate Barstool Sports content and describes the new company policy of not being mean. Blind Mike gets years worth of built up frustration out. Matt Carano and Gerry Callahan officially part ways. Carl Stevens of WBZ shares a poem about the legacy of David Ortiz. Chris' mall design game & more!

Daver and Danny review last year's post-Thanksgiving show: A tremendous amount of negative feedback to the new Kirk Minihane merchandise released on Black Friday... So bad you need to have it. Kirk is ready for The Dozen Live at the House of Blues. Howard Stern promotes his HBO Max special on Morning Joe. Mike fills us in on an interesting performance on Brazil's Got Talent. Jeff D Lowe calls in with some trivia questions & a HOF caller makes his KMS debut”

Montante is in producing one last time to make one last cast for the full time producer role. Blind Mike is joined by Daver from Hull. Kirk recaps a wild match in the Writer Cup. Jeremy Schneider joins us with a defense of his David Portnoy article. Daver has a long terrible game. A new big three is formed. Steve Lappas has a son who is a Minifan. A Barstool radio crossover to end the show & more.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow

Danny in Billerica and Daver from Hull in-studio. As it stands, Plymouth is cash-only for alcohol sales (00:02:00). Menners is on thin ice after saying he wants to copy 'Quantum Kirk' with different people basically every night. (00:08:00). Kelly Keegs calls Kirk a chauvinist but doesn't respond to requests to come on the show (00:19:00). Slate has an article on Dave Portnoy's impact on the pizza business that includes a questionable quote from a restaurant that made a lot of money off his review (00:35:40). Kirk does not want Live Events Lisa to speak with his producer without him knowing anymore (00:43:00), calls & more.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/kminshow